Testosterone Cypionate in Grapeseed Oil Injectable, 100 mg/mL, a) 1mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
Published January 11, 2017 · Recall initiated: September 21, 2016
Summary
FDA records drug Class II recall D-0400-2017, published January 11, 2017 and initiated September 21, 2016. Recalling firm: Wells Pharmacy Network LLC; Status: Terminated; Reported quantity: a ) 303 vials and b) 413 vials; Lot: All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known lot code: 04212016@5, 05102016@123, 05232016@21, 07132016@18 b) Known lot code: 04142016@7, 05042016@6, 05252016@2, 06222016@30, 07132016@25, 07282016@5. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Wells Pharmacy Network LLC
- Distributor
- Nationwide
- Lot
- All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known lot code: 04212016@5, 05102016@123, 05232016@21, 07132016@18 b) Known lot code: 04142016@7, 05042016@6, 05252016@2, 06222016@30, 07132016@25, 07282016@5.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAQUAD1(PAP/PHEN/ALPROS/ATRO) 0.9 mg/0.2 mg/20 mcg/0.01 mg/mL Injectable, a) 2 mL and b) 5 mL vials, CompoundedJanuary 11, 2017
- FDASermorelin Acetate/GHRP (2) 9 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala FLJanuary 11, 2017
- FDATestosterone Cypionate in Sesame Oil Injectable, 210 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala,January 11, 2017
- FDAAlprostadil 20 mcg/mL Injectable, a) 5 mL and b) 10 mL vials, Compounded by Wells Pharmacy Network LLC, OcalaJanuary 11, 2017
- FDATestosterone Cypionate / Zinc Sulf in Grapeseed Oil Injectable, 200 mg/200 mcg/mL, 10 mL vial, Compounded byJanuary 11, 2017
- FDATestosterone Cypionate in Grapeseed Oil Injectable, 20 mg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala,January 11, 2017
Questions about this recall
Was Testosterone Cypionate in Grapeseed Oil Injectable, 100 mg/mL, a) 1mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL recalled?
Yes. FDA published recall D-0400-2017 on January 11, 2017. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Press Release